Search

Another China-based chemical company was indicted for allegedly selling precursor chemicals and xylazine to U.S. buyers as Americans continue to grapple with the toll of counterfeit prescription pills made with dangerous drugs.

Dominican-Republic-bust-Nov-2024

November 12, 2024

Diario Libre, November 2024

Hubei-Aoks-Bio-Tech-Sales

November 12, 2024

Product listing for a fentanyl precursor marketed by Hubei Aoks Bio-Tech. (Screenshot, November 2024)

Indictment, USA v Hubei Aoks Bio-Tech Co and Xuening Gao et al

November 8, 2024

Posted in 18 USC § 982 Criminal Forfeiture, 21 USC § 352(o) Drugs or devices from nonregistered establishments, 21 USC § 853 - Criminal forfeitures, 21 USC § 959 (a) Distribution of listed chemicals for importation, 21 USC § 960 - Prohibited acts A, 21 USC § 963 Attempt and conspiracy, 21 USC §§ 331 and 333 Unapproved drugs, 21 USC §§ 841 Federal Controlled Substances Act violations, 21 USC §§ 846 Federal Controlled Substances Act - conspiracy, 28 USC §2461(c) Forfeiture, Article Topic, Prosecution Documents Library

United States District Court Central District of Calfornia USA v Hubei Aoks Bio-Tech Co and Xuening Gao et al Indictment Filed May 10, 2024 Read the document.

Indictment-Hubei-Aoks-Bio-Tech

November 8, 2024

Search

Sort by

Category

Post Type

Novo Nordisk v Midwest Aesthetic Management

Novo Nordisk v Old Town Medspa

Novo Nordisk v Chicago Weight Loss and Wellness Clinics

Novo Nordisk v Ambrose Medical

Novo Nordisk v Rejuvae Boutique

November 11, 2024: Feds pursue companies selling fentanyl precursors

Dominican-Republic-bust-Nov-2024

Hubei-Aoks-Bio-Tech-Sales

Indictment, USA v Hubei Aoks Bio-Tech Co and Xuening Gao et al

Indictment-Hubei-Aoks-Bio-Tech